ClinicalTrials.Veeva

Menu

Carcinologic Speech Severity Index (C2SI)

T

Toulouse University Hospital

Status

Completed

Conditions

Head and Neck Cancer

Treatments

Procedure: automatic speech processing tool

Study type

Interventional

Funder types

Other

Identifiers

NCT02875795
14 7414 07

Details and patient eligibility

About

The hypothesis of the present study is that an automatic assessment technic can measure the impact of the speech disorders on the communication abilities giving a severity index of speech in patients treated for head and neck and particularly for oral and pharyngeal cancer.

Enrollment

124 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Oral and Pharyngeal cancer T2 to T4 for having a wide dynamic of deficit
  • Treatment by surgery and/or radiotherapy and/or chemotherapy
  • Delay after the end of the treatment of minimum 6 months.

Exclusion criteria

  • Patients with a previous speech disorders (ie stuttering... )
  • Patients not able to perform the whole task

Trial design

Primary purpose

Prevention

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

124 participants in 1 patient group

speech intelligibility
Experimental group
Description:
speech intelligibility is registered by an automatic speech processing tool
Treatment:
Procedure: automatic speech processing tool

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems